Charmacy Pharmaceutical Co., Ltd. (HKG:2289)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.47
0.00 (0.00%)
Jun 3, 2026, 3:47 PM HKT
Market Cap590.76M -29.4%
Revenue (ttm)4.88B -1.1%
Net Income51.49M -13.2%
EPS0.48 -13.2%
Shares Out 108.00M
PE Ratio11.47
Forward PEn/a
Dividend0.35 (6.34%)
Ex-Dividend DateMay 27, 2026
Volume2,000
Open5.47
Previous Close5.47
Day's Range5.47 - 5.47
52-Week Range4.30 - 7.40
Beta-0.92
Analystsn/a
Price Targetn/a
Earnings DateMar 27, 2026

About Charmacy Pharmaceutical

Charmacy Pharmaceutical Co., Ltd. engages in the pharmaceutical distribution business in the People’s Republic of China. It distributes western medicines, Chinese patent medicines, healthcare products, and pharmaceutical products to downstream distributors and retail terminals. The company also offers pharmaceutical product related consulting services; and operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online, make inquires, and payments, etc. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and chan... [Read more]

Sector Healthcare
Founded 1984
Employees 847
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2289
Full Company Profile

Financial Performance

In 2025, Charmacy Pharmaceutical's revenue was 4.38 billion, a decrease of -1.15% compared to the previous year's 4.44 billion. Earnings were 46.27 million, a decrease of -13.16%.

Financial numbers in CNY Financial Statements